Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | RARB | P10826 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RARA | P10276 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14384733 | 0.89 | GAA (0.46) | GAAL3MBTL1RARBAPPPLA2G4B | |
| SCHEMBL13799315 | 0.86 | PLA2G4B (0.47) | GAARARBPLA2G4B | |
| SCHEMBL13799305 | 0.86 | MAOB (0.50) | L3MBTL1 | |
| SCHEMBL13799314 | 0.81 | PLA2G4B (0.40) | GAAL3MBTL1RARBPLA2G4B | |
| SCHEMBL5054847 | 0.79 | HDAC1 (0.54) | GAAL3MBTL1 | |
| SCHEMBL30917919 | 0.78 | CES2 (0.42) | GAATSHR | |
| SCHEMBL14566123 | 0.77 | NR5A1 (0.83) | NR5A1GAALTA4HRARBAPP | |
| SCHEMBL840786 | 0.77 | NR5A1 (0.83) | NR5A1GAALTA4HRARBAPP | |
| SCHEMBL10357881 | 0.77 | NR5A1 (0.83) | NR5A1GAALTA4HRARBAPP | |
| SCHEMBL840785 | 0.77 | NR5A1 (0.83) | NR5A1GAALTA4HRARBAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090163380-A1 | ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY | STRATOS BIOSYSTEMS, LLC (US) | 2009-06-25 | — | — | US | disclosed |
| US-20090163380-A1 | ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY | STRATOS BIOSYSTEMS, LLC (US) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163380-A1 | ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY | STUB1, SPR, DBI | NR5A1 2146/4885GAA 1805/4885LTA4H 3319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.